RHB.JSE RH Bophelo Ltd
- Market cap
- ZAC 77.6M
- P/E
- 4.1x
- P/B
- 0.07x
- ROE
- 1.7%
- Dividend yield
- -
- Fundamental score
- 1.8/5
Ratios use the latest price and the fiscal year ending Feb 2026.
Is RHB.JSE undervalued?
Graham numberThe Graham number of RH Bophelo Ltd cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
RH Bophelo Ltd fundamental analysis
8 of 22 checks passedROE 0/2
Low return on equity (1.7%), below 10%.
ROA 0/1
Return on assets (1.5%) is below the industry median (5.9%).
Profit Consistency 1/2
Profitable for 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share did not grow over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-57.7%) is not above the 5-year average (-33.3% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (-57.7%) is below the industry median (-19.9%).
Revenue Growth 2/2
Revenue grew 31.1% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 0/1
Current assets do not cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (2.5%), 40% or less.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Operating cash flow does not cover 20% of total debt.
Interest Coverage 0/1
EBIT is 2.3x against interest expense, below 5x.
PE vs Market 1/1
PE (4.1x) is below the market median (9.1x).
PE vs Industry 1/1
PE (4.1x) is below the industry median (22.9x).
PBV 1/1
Price to book (0.1x) is below the industry median (1.4x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 0.3, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
RH Bophelo Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About RH Bophelo Ltd
RH Bophelo Limited, together with its subsdidiaries, invests in the healthcare and financial sector in South Africa. It is involved in investment of equity, quasi-equity, and equity related investments in operational infrastructure, health insurance, private hospital infrastructure, pharmaceuticals, retail and distribution, and healthcare technology. The company was incorporated in 2016 and is based in Johannesburg, South Africa. RH Bophelo Limited operates as a subsidiary o…
Full company profileRH Bophelo Ltd financial statements
RH Bophelo Ltd annual financial statements (ZAR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | - | 20.8M | 24.5M | 21.5M | 14.8M | 31.8M | 39.8M | 41.3M | 39.8M | 89.6M |
| Gross Profit | - | 18.4M | 41.3M | 21.3M | 7.52M | 26.4M | 34.8M | 285M | 112M | 83.0M |
| Operating Income | - | 8.31M | 30.7M | 6.44M | 173M | 81.3M | -25.0M | 8.73M | 92.5M | 27.0M |
| EBITDA | - | 8.70M | 28.1M | 90.5M | 167M | 65.6M | -36.5M | 253M | 72.5M | 28.0M |
| Net Income | - | 7.84M | 21.2M | 70.0M | 131M | 53.5M | -32.2M | 183M | 43.9M | 18.6M |
| EPS | - | 0.16 | 0.42 | 1.31 | 2.18 | 0.83 | -0.50 | 2.82 | 0.68 | 0.29 |
| Balance Sheet | ||||||||||
| Total Assets | 1.00 | 499M | 536M | 671M | 926M | 976M | 1.03B | 1.22B | 1.28B | 1.26B |
| Total Liabilities | 0.00 | 3.52M | 5.43M | 24.6M | 61.6M | 72.4M | 162M | 182M | 205M | 162M |
| Shareholders' Equity | 1.00 | 496M | 530M | 647M | 864M | 904M | 872M | 1.03B | 1.08B | 1.10B |
| Cash & Short-term Investments | 0.00 | 3.58M | 374M | 120M | 34.7M | 7.76M | 152M | 54.7M | 30.0M | 27.2M |
| Total Debt | - | - | - | 3.64M | 3.64M | 2.98M | 105M | 73.4M | 71.6M | 27.8M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 0.00 | 11.4M | 5.11M | 4.60M | -11.7M | 3.76M | 10.3M | -33.8M | 2.34M | -16.5M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 45.6K | 3.00 | 45.6K | 45.6K | 80.2K | 48.6K | 0.00 |
| Free Cash Flow | - | 11.4M | 5.11M | 4.60M | -11.7M | 3.76M | 10.2M | -33.9M | 2.29M | -16.5M |
| Ratios | ||||||||||
| ROE | - | 1.6% | 4.0% | 10.8% | 15.2% | 5.9% | -3.7% | 17.7% | 4.1% | 1.7% |
| ROA | - | 1.6% | 4.0% | 10.4% | 14.2% | 5.5% | -3.1% | 15.0% | 3.4% | 1.5% |
| Net Profit Margin | - | 37.6% | 86.4% | 325.1% | 887.4% | 168.3% | -80.9% | 442.6% | 110.3% | 20.7% |
| Debt to Equity | - | - | - | 0.01x | 0.00x | 0.00x | 0.12x | 0.07x | 0.07x | 0.03x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
RH Bophelo Ltd dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Dec 12, 2023
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | ZAR 20.1M | 0.31 | 11.0% |
| 2023 | - | - | - |
| 2022 | ZAC 13.6M | 0.21 | 25.4% |
| 2021 | ZAC 13.6M | 0.23 | 10.4% |
| 2020 | ZAC 13.6M | 0.25 | 19.4% |
| 2019 | ZAC 13.6M | 0.27 | 64.3% |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns RH Bophelo Ltd
- Insiders 24.83%
- Institutions 72.31%
- Public & others 2.87%
- Shares outstanding 64.7M
- Free float 4.96M
RH Bophelo Ltd company profile
- Company name
- RH Bophelo Ltd
- Ticker
- RHB.JSE
- ISIN
- ZAE000244737
- Exchange
- Johannesburg Exchange
- Sector
- Financial Services
- Industry
- Health Care Providers & Services
- Fiscal year end
- February
- Address
- RH Bophelo, Unit 12, Johannesburg, South Africa, 2191
- Phone
- 27 10 007 2171
- Website
- rhbophelo.co.za
About RH Bophelo Ltd
RH Bophelo Limited, together with its subsdidiaries, invests in the healthcare and financial sector in South Africa. It is involved in investment of equity, quasi-equity, and equity related investments in operational infrastructure, health insurance, private hospital infrastructure, pharmaceuticals, retail and distribution, and healthcare technology. The company was incorporated in 2016 and is based in Johannesburg, South Africa. RH Bophelo Limited operates as a subsidiary of Public Investment Corporation SOC Limited.
RH Bophelo Ltd management
3- Mr. Quinton Zunga B.Bus.Sci., M.Sc., MScMD, CEO & Executive Director · born 1978
- Ms. Aviwe Yondie Metu C.A.CFO & Executive Director · born 1985
- Mr. Colin Wayne Clarke III, BA(Pol.Sc.), J.D., MBAChief Investment Officer & Executive Director · born 1967